Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer
MA40344AUndetermined Publication Date: 2016-01-21ADVAXIS INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA40344
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-08-19
- Filing Date
- 2015-07-17
- Publication Date
- 2016-01-21
Abstract
The present disclosure describes combination therapies comprising an antagonist of programmed death 1 receptor (pd-1) and a
Need to check novelty before this filing date? Find Prior Art